Trials / Completed
CompletedNCT05447897
Designing an Implementation Strategy for Lung Screening and Smoking Cessation Treatment in Community Health Centers
A Systematic Approach to Designing an Implementation Strategy to Increase Lung Cancer Screening and Smoking Cessation Treatment Among Federally Qualified Community Health Center Patients Who Smoke
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 9 (actual)
- Sponsor
- University of Colorado, Denver · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
Tobacco use is the leading preventable cause of death in the US and a major driver of health disparities. Among our tools for reducing the harms of tobacco is lung cancer screening (LCS). This study will combine a review of existing qualitative and quantitative data on barriers to lung cancer screening and smoking cessation in underserved populations, a quantitative analysis of predictors of lung cancer screening and smoking cessation treatment use among Massachusetts Federally Qualified Health Centers (FQHC)s, and a stakeholder advisory group to synthesize these data and select implementation strategies that reflects the critical determinants and the strengths and resource constraints of the Federally Qualified Health Centers (FQHC) context.
Detailed description
Aim 1) To design an implementation strategy that targets critical components in the delivery of SCT or LCS services for patients who smoke. Aim 2) To assess the acceptability, appropriateness and feasibility of the implementation strategy among community health center staff.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Qualitative Group Interviews | One time interview, 60-90 minutes |
| OTHER | Stakeholder advisory group | The team will meet with the stakeholder advisory group four times for 1-2 hours each |
Timeline
- Start date
- 2022-12-01
- Primary completion
- 2023-05-31
- Completion
- 2023-05-31
- First posted
- 2022-07-07
- Last updated
- 2024-04-16
- Results posted
- 2024-04-16
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05447897. Inclusion in this directory is not an endorsement.